# COU-AA-302 (NCT00887198)

> Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00887198
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Janssen Research & Development, LLC
- Conditions: Prostate Cancer
- Interventions: Abiraterone acetate; Placebo; Prednisone
- Enrollment: 1088
- Primary outcome: Overall Survival
- Primary outcome: Radiographic Progression-free Survival (rPFS)

## Indexed commentary on COU-AA-302 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- Podcasts: 2
- X threads: 2
- X videos: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=cou-aa-302-nct00887198